Kaivogen Oy is a Finnish biotech company established in 2007. The kaivo in the company name is Finnish for the well of a microplate and relates to the company’s very first products, streptavidin coated plates. Since its start up with these products, Kaivogen has extended its portfolio year by year. Current products include a wide range of assay development services from kit manufacturing to custom plate production, custom biomolecule conjugation and custom buffer preparation. In addition, we provide various streptavidin and anti-species plates and buffer products as catalogue items. Also check out our Upcon® nanoparticle-based detection technology that is well suited for lateral flow applications. Kaivogen's main customer group consists of IVD companies, for whom Kaivogen acts as an OEM manufacturer of components for IVD assays and kits. Other customer groups include research foundations and academic research groups. Around 90% of Kaivogen’s turnover each year comes from exported products, the main export destinations being the USA and the Nordic countries. Kaivogen Oy has been found to conform to the management system standards ISO 9001:2015/ISO 13485:2016 in development, manufacturing and distribution of coated microtiter plates and components for bioaffinity assays. Also our custom services, such as assay development, plate coating and protein labeling can be ISO 13485 compliant if necessary.